Gilad Mamlok

Gilad Mamlok is an accomplished finance professional currently serving as the Chief Financial Officer at TytoCare since July 2024. Mamlok previously held the CFO position at Sol-Gel Technologies from February 2017 to July 2024, where a successful IPO was executed in 2018, raising over US $150 million. Prior to this, Mamlok was CFO at Medigus and VP Finance at Minimally Invasive Therapies Group (Covidien). At Given Imaging, as SVP of Global Finance and Accounting, Mamlok played a key role in the company's revenue growth from $86M to $191M between 2005 and 2013. Mamlok's early career includes finance leadership roles at Metacure, Simbionix, and Nice Systems, as well as serving as a Director in the Israeli Ministry of Defense. Academic qualifications include a PhD in Economics from the University of Rochester and Master's and Bachelor's degrees in Economics from Tel Aviv University.